Figure 1.
Flow chart of the study participants through the phases of the randomised controlled trial. Data were collected at Uppsala University Hospital, Sweden between November 1st, 2016 and December 18th, 2018. Individuals were randomised within one week after baseline assessment. No adverse events were reported.